Overview
- 106 inspections across 105 sites are on record.
- 285 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-02-18.
At a glance
Inspections
106
Sites
105
Observations
285
Career since
Mar 2015
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Gilead Sciences, Inc. | 18 Feb 2026 | Human Drugs | On file |
| Innovatical Laboratories Llc | 16 Jan 2026 | Human Drugs | On file |
| Skytronics Led, Inc | 12 Jan 2026 | Human Drugs | On file |
| Corden Pharma Colorado, Inc. | 14 Nov 2025 | Human Drugs | |
| Nelson Laboratories, LLC | 26 Sep 2025 | Human Drugs | On file |
Sites inspected
Gilead Sciences, Inc.La Verne, United States1 insp.
Innovatical Laboratories LlcMontclair, United States1 insp.
Skytronics Led, IncBurbank, United States1 insp.
Corden Pharma Colorado, Inc.Boulder, United States1 insp.
Nelson Laboratories, LLCItasca, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Norman K Starks4 shared
Guerlain Ulysse2 shared
Karen L Rothschild2 shared
Michele L Glendenning2 shared
Debra I Love2 shared
Maria Diaz2 shared
Patrick E Gainer2 shared
Devisree P Mattigiri1 shared
Elvis Patel1 shared
Pearl C Ozuruigbo1 shared
Full investigator report
Get the verbatim findings behind Bryan L Mcguckin's 285 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site